Expression and Prognostic Analyses of ITGA3, ITGA5, and ITGA6 in Head and Neck Squamous Cell Carcinoma

Overview

Journal Med Sci Monit

Specialties General Medicine
Pathology

Date 2020 Oct 25

PMID 33099569

Citations 10

Authors

Chen Feng

Xiaoxue Jin

Yingying Han

Ruixiang Guo

Juanjuan Zou

Yanzhong Li

Yan Wang

Affiliations

Soon will be listed here.

Abstract

BACKGROUND The landscape of head and neck cancers has changed with improvements in standard therapy; however, it is necessary to exploit advanced genomic approaches to identify novel diagnostic and prognostic biomarkers for head and neck squamous cell carcinoma (HNSC). ITGA3, ITGA5, and ITGA6, members of the integrin family of proteins, play active roles in cytoskeletal organization and cell migration, proliferation, and survival. However, the expression patterns and prognostic values of ITGA3, ITGA5, and ITGA6 in head and neck squamous cell carcinoma remain unclear. MATERIAL AND METHODS Different expression patterns and prognostic values of ITGA3, ITGA5, and ITGA6 were analyzed in patients with HNSC using various databases, including ONCOMINE, GEPIA, TIMER, HPA, Kaplan-Meier Plotter, GEO, and TCGA. RESULTS Expression levels of ITGA3, ITGA5, and ITGA6 were substantially increased in patients with HNSC. Additionally, higher expression levels of ITGA3, ITGA5, and ITGA6 were associated with worse overall survival in patients with HNSC, and higher levels of ITGA3 correlated with a worse relapse-free survival. CONCLUSIONS ITGA3, ITGA5, and ITGA6 are potential diagnostic and prognostic biomarkers for HNSC. In particular, IGTA5 might be used as a significant independent prognostic factor in this cancer.

Citing Articles

Molecular docking and analysis of the pharmacokinetics, toxicological profile and differential gene expression of bioactive compounds from .

Araujo N, da Silva Junior F, Santos L, Batistuzzo de Medeiros S, Felzenszwalb I, Araujo-Lima C Toxicol Rep. 2024; 13:101810.

PMID: 39629241 PMC: 11612344. DOI: 10.1016/j.toxrep.2024.101810.

ITGA5 is associated with prognosis marker and immunosuppression in head and neck squamous cell carcinoma.

Liu J, Wang Y, Chen X, Chen X, Zhang M Diagn Pathol. 2024; 19(1):134.

PMID: 39375732 PMC: 11457354. DOI: 10.1186/s13000-024-01559-1.

Advanced Analysis and Validation of a microRNA Signature for Fanconi Anemia.

Cappelli E, Ravera S, Bertola N, Grilli F, Squillario M, Regis S Genes (Basel). 2024; 15(7).

PMID: 39062599 PMC: 11276059. DOI: 10.3390/genes15070820.

Regulation and Functions of α6-Integrin (CD49f) in Cancer Biology.

Khademi R, Malekzadeh H, Bahrami S, Saki N, Khademi R, Villa-Diaz L Cancers (Basel). 2023; 15(13).

PMID: 37444576 PMC: 10341356. DOI: 10.3390/cancers15133466.

ACTN1 interacts with ITGA5 to promote cell proliferation, invasion and epithelial-mesenchymal transformation in head and neck squamous cell carcinoma.

Wang R, Gao Y, Zhang H Iran J Basic Med Sci. 2023; 26(2):200-207.

PMID: 36742137 PMC: 9869876. DOI: 10.22038/IJBMS.2022.67056.14703.

References

Koshizuka K, Hanazawa T, Kikkawa N, Arai T, Okato A, Kurozumi A . Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer. Cancer Sci. 2017; 108(8):1681-1692. PMC: 5543473. DOI: 10.1111/cas.13298. View

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

Chow L . Head and Neck Cancer. N Engl J Med. 2020; 382(1):60-72. DOI: 10.1056/NEJMra1715715. View

Pan J, Zhou H, Cooper L, Huang J, Zhu S, Zhao X . LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers. Front Immunol. 2019; 10:6. PMC: 6362421. DOI: 10.3389/fimmu.2019.00006. View

Hsu Y, Chen H, Yuan S, Yu S, Lin C, Wu G . Genome-wide analysis of three-way interplay among gene expression, cancer cell invasion and anti-cancer compound sensitivity. BMC Med. 2013; 11:106. PMC: 3635895. DOI: 10.1186/1741-7015-11-106. View

Murillo C, Rychahou P, Evers B . Inhibition of alpha5 integrin decreases PI3K activation and cell adhesion of human colon cancers. Surgery. 2004; 136(2):143-9. DOI: 10.1016/j.surg.2004.04.006. View

Gyorffy B, Lanczky A, Szallasi Z . Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients. Endocr Relat Cancer. 2012; 19(2):197-208. DOI: 10.1530/ERC-11-0329. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2016. CA Cancer J Clin. 2016; 66(1):7-30. DOI: 10.3322/caac.21332. View

Stewart R, West D, Wang C, Weiss H, Gal T, Durbin E . Elevated integrin α6β4 expression is associated with venous invasion and decreased overall survival in non-small cell lung cancer. Hum Pathol. 2016; 54:174-83. PMC: 4938774. DOI: 10.1016/j.humpath.2016.04.003. View

10.

Linhares M, Affonso Jr R, de Souza Viana L, Silva S, Denadai M, de Toledo S . Genetic and Immunohistochemical Expression of Integrins ITGAV, ITGA6, and ITGA3 As Prognostic Factor for Colorectal Cancer: Models for Global and Disease-Free Survival. PLoS One. 2015; 10(12):e0144333. PMC: 4682960. DOI: 10.1371/journal.pone.0144333. View

11.

Son S, Lee S, Singh D, Lee N, Lee D, Lee C . Comprehensive Secondary Metabolite Profiling Toward Delineating the Solid and Submerged-State Fermentation of KCCM 12698. Front Microbiol. 2018; 9:1076. PMC: 5981208. DOI: 10.3389/fmicb.2018.01076. View

12.

Ginos M, Page G, Michalowicz B, Patel K, Volker S, Pambuccian S . Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res. 2004; 64(1):55-63. DOI: 10.1158/0008-5472.can-03-2144. View

13.

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu J . TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017; 77(21):e108-e110. PMC: 6042652. DOI: 10.1158/0008-5472.CAN-17-0307. View

14.

Raghavachari N, Barb J, Yang Y, Liu P, Woodhouse K, Levy D . A systematic comparison and evaluation of high density exon arrays and RNA-seq technology used to unravel the peripheral blood transcriptome of sickle cell disease. BMC Med Genomics. 2012; 5:28. PMC: 3428653. DOI: 10.1186/1755-8794-5-28. View

15.

Behnsawy H, Miyake H, Abdalla M, Sayed M, Ahmed A, Fujisawa M . Expression of integrin proteins in non-muscle-invasive bladder cancer: significance of intravesical recurrence after transurethral resection. BJU Int. 2010; 107(2):240-6. DOI: 10.1111/j.1464-410X.2010.09534.x. View

16.

Gong C, Yang Z, Wu F, Han L, Liu Y, Gong W . miR-17 inhibits ovarian cancer cell peritoneal metastasis by targeting ITGA5 and ITGB1. Oncol Rep. 2016; 36(4):2177-83. DOI: 10.3892/or.2016.4985. View

17.

Rhodes D, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs B . Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia. 2007; 9(2):166-80. PMC: 1813932. DOI: 10.1593/neo.07112. View

18.

Bonner J, Harari P, Giralt J, Cohen R, Jones C, Sur R . Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol. 2009; 11(1):21-8. DOI: 10.1016/S1470-2045(09)70311-0. View

19.

Leemans C, Snijders P, Brakenhoff R . The molecular landscape of head and neck cancer. Nat Rev Cancer. 2018; 18(5):269-282. DOI: 10.1038/nrc.2018.11. View

20.

Pyeon D, Newton M, Lambert P, den Boon J, Sengupta S, Marsit C . Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res. 2007; 67(10):4605-19. PMC: 2858285. DOI: 10.1158/0008-5472.CAN-06-3619. View